Digital Biomanufacturing Market Size, Share Analysis, Industry Insights, Growth, And Forecast To 2033

The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.

Digital Biomanufacturing Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.

The Market Size Is Expected To Reach $35.01 billion In 2028 At A CAGR Of 12.9% :

The digital biomanufacturing market size has grown rapidly in recent years. It will grow from $18.87 billion in 2023 to $21.57 billion in 2024 at a compound annual growth rate (CAGR) of 14.3%. The growth in the historic period can be attributed to increasing complexity of biopharmaceuticals, rise in personalized medicine, demand for cost-effective production, bioprocess optimization, quality control and regulatory compliance.

The digital biomanufacturing market size is expected to see rapid growth in the next few years. It will grow to $35.01 billion in 2028 at a compound annual growth rate (CAGR) of 12.9%. The growth in the forecast period can be attributed to blockchain for supply chain transparency, advanced process control (APC) systems, emphasis on sustainability, interconnected biomanufacturing ecosystems, biomanufacturing in emerging markets. Major trends in the forecast period include integration of artificial intelligence (AI), digital twins for bioprocessing, advancements in biotechnology, Industry 4.0 integration, real-time monitoring and control.

Request A Sample Of This Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=10828&type=smp

Digital Biomanufacturing Market Major Segments
The digital biomanufacturing market covered in this report is segmented -

1) By Type: Manufacturing Technologies, Analytical And Process Control Technologies, Software, Other Types
2) By Types of Biologic(s) Manufactured: Antibodies, Cell And Gene Therapies, Proteins, Vaccines, Other Types
3) By Technology: AI And IoMT Solutions, Process Analytical Technologies, Data Analytics Software, Predictive Analytics And Digital Twin Technologies, Other Technologies
4) By Application: BioProcess Optimization, Biomanufacturing Process Automation And Control, Other Applications
5) By End User: Biopharmaceutical Companies, Academic And Research Institutes

Key Driver - Accelerating Growth In The Digital Biomanufacturing Market Amid Rising Demand

The growing demand for biologics is expected to propel the growth of the digital biomanufacturing market going forward. Biologicals are a vast class of pharmaceuticals that include vaccines, growth factors, immunological modulators, monoclonal antibodies, and drugs produced from human blood and plasma. Digital biomanufacturing is used to enhance biologics production by optimizing processes, quality control, lowering costs, and shortening production time, which helps producers to embrace data-driven methodologies and advanced technology to satisfy rising biologics demand more efficiently and sustainably. For instance, in January 2021, according to US Food and Drug Administration, a US-based federal agency of the Department of Health and human services, the Center for drug evaluation and Research (CDER), authorized 37 innovative pharmaceuticals in 2022, either as new molecular entities (NMEs) through new drug applications (NDAs) or as new therapeutic biological products through biologics license applications (BLAs). Further, according to the National Library of Medicine, a US-based center of biomedical informatics and computational biology, there were 14 biologics approvals and authorization of 36 small molecules in 2021. Therefore, the growing demand for biologics is driving the digital biomanufacturing market.

Customise This Report As Per Your Requirements - https://www.thebusinessresearchcompany.com/Customise?id=10828&type=smp

Prominent Trend - Innovative Solutions For A Sustainable Future In Digital Biomanufacturing

Major companies operating in the market are focusing on innovative solutions like single-use bioprocessing systems to sustain their position in the market. Single-Use Bioprocessing Systems enhance digital biomanufacturing with flexibility, real-time monitoring, reduced contamination risks, and cost-efficiency. For instance, in October 2022, PharmNXT Biotech LLP, an India-based biotech startup, has launched its first integrated manufacturing unit in Pune to provide single-use bioprocessing solutions. The state-of-the-art facility has been launched to address the challenges of biologics manufacturing in the country. The new facility will generate employment opportunities for over 100 to 200 people and will cater to the demands from global markets such as Singapore, Korea, Europe & the US. The ekuse manufacturing facility will be engaged in crafting the Xelta range of single-use bioprocessing products and 'NXTmix' a levitating mixing technology.

Digital Biomanufacturing Market Players
Major companies operating in the digital biomanufacturing market report are Sanofi SA, Thermo Fisher Scientific Inc., Honeywell International Inc., 3M Company, SAP SE, Danaher Corporation, ABB AG, Siemens Healthineers AG, Emerson Electric Co, GE HealthCare Technologies Inc., Atos SE, Agilent Technologies Inc., Cytiva Europe GmbH, Lonza Group AG, Dassault Systèmes SE, Sartorius AG, BioMérieux, Donaldson Company Inc., Pall Corporation, Eppendorf AG, Xenon Pharmaceuticals Inc., Symphony Innovation LLC, Koch Membrane Systems Inc., Culture Biosciences Inc., Bota Biosciences Inc., Xenex Laboratories Inc., Shimadzu Corporation, e-MSion, Exponential Genomics Inc., Immersciobio GmbH

View The Full Report Here - https://www.thebusinessresearchcompany.com/report/digital-biomanufacturing-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the digital biomanufacturing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global digital biomanufacturing market during the forecast period. The regions covered in the digital biomanufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Digital Biomanufacturing Market Report Structure
3. Digital Biomanufacturing Market Trends And Strategies
4. Digital Biomanufacturing Market - Macro Economic Scenario
5. Digital Biomanufacturing Market Size And Growth
…..
27. Digital Biomanufacturing Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Want To Know More About The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.